HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study.

AbstractINTRODUCTION:
Description of a continuous hypertonic saline solution (HSS) infusion using a dose-adaptation of natremia in traumatic brain injured (TBI) patients with refractory intracranial hypertension (ICH).
METHODS:
We performed a single-center retrospective study in a surgical intensive care unit of a tertiary hospital. Fifty consecutive TBI patients with refractory ICH treated with continuous HSS infusion adapted to a target of natremia. In brief, a physician set a target of natremia adapted to the evolution of intracranial pressure (ICP). Flow of NaCl 20% was a priori calculated according to natriuresis, and the current and target natremia that were assessed every 4 hours.
RESULTS:
The HSS infusion was initiated for a duration of 7 (5 to 10) (8 ± 4) days. ICP decreased from 29 (26 to 34) (31 ± 9) mm Hg at H0 to 20 (15 to 26) (21 ± 8) mm Hg at H1 (P < 0.05). Cerebral perfusion pressure increased from 61 (50 to 70) (61 ± 13) mm Hg at H0 up to 67 (60 to 79) (69 ± 12) mm Hg at H1 (P < 0.05). No rebound of ICH was reported after stopping continuous HSS infusion. Natremia increased from 140 (138 to 143) (140 ± 4) at H0 up to 144 (141 to 148) (144 ± 4) mmol/L at H4 (P < 0.05). Plasma osmolarity increased from 275 (268 to 281) (279 ± 17) mmol/L at H0 up to 290 (284 to 307) (297 ± 17) mmol/L at H24 (P < 0.05). The main side effect observed was an increase in chloremia from 111 (107 to 119) (113 ± 8) mmol/L at H0 up to 121 (117 to 124) (121 ± 6) mmol/L at H24 (P < 0.05). Neither acute kidney injury nor pontine myelinolysis was recorded.
CONCLUSIONS:
Continuous HSS infusion adapted to close biologic monitoring enables long-lasting control of natremia in TBI patients along with a decreased ICP without any rebound on infusion discontinuation.
AuthorsAntoine Roquilly, Pierre Joachim Mahe, Dominique Demeure Dit Latte, Olivier Loutrel, Philippe Champin, Christelle Di Falco, Athanase Courbe, Kevin Buffenoir, Olivier Hamel, Corinne Lejus, Véronique Sebille, Karim Asehnoune
JournalCritical care (London, England) (Crit Care) Vol. 15 Issue 5 Pg. R260 ( 2011) ISSN: 1466-609X [Electronic] England
PMID22035596 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Saline Solution, Hypertonic
  • Sodium
Topics
  • Adult
  • Brain Injuries (blood, physiopathology, therapy)
  • Dose-Response Relationship, Drug
  • Female
  • Fluid Therapy (methods)
  • Humans
  • Infusions, Intravenous (methods)
  • Intracranial Hypertension (blood, complications)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Saline Solution, Hypertonic (administration & dosage)
  • Sodium (blood)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: